MedPath

XO SKYNLAB GLUTASNOW CAPSULE

Registration Number: MAL19046019NC

Approved
Approval ID

15453ac7e42a755e

Registration Number

MAL19046019NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types5 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (5)

10 CapsulesAvailable
Package Size: 10 Capsules
Status: NPRA Approved
15 CapsulesAvailable
Package Size: 15 Capsules
Status: NPRA Approved
30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
50 CapsulesAvailable
Package Size: 50 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (7)

L-CYSTEINEActive
Monograph: 半胱氨酸
COENZYME Q10 (UBIQUINONE)Active
Monograph: coenzyme q 10 (ubiquinone)
ASCORBYL PALMITATEActive
Monograph: ascorbyl palmitate
HAEMATOCOCCUS PLUVIALIS EXTRACTActive
Monograph: haematococcus pluvialis extract
L-GLUTATHIONEActive
Monograph: l-glutathione
ASCORBIC ACID (VITAMIN C)Active
Monograph: ascorbic acid (vitamin c)
LYCOPERSICON ESCULENTUM (TOMATO)Active
Monograph: lycopersicon esculentum (tomato)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

XO SKYNLAB GLUTASNOW CAPSULE - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform